Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wombat Capital Markets is a U.S. registered broker-dealer and investment banking advisory firm operating under the Wombat Capital brand. The firm focuses on cross-border M&A, capital raising, valuation, restructuring, joint ventures, and strategic advisory assignments, with particular coverage of pharma outsourcing, medical devices, and diagnostics. Although it serves healthcare-related industries, it is not a drug-development, biotech, pharma, or healthcare operating company. It appears to function primarily as a sector-focused financial intermediary for lower middle-market and strategic transactions rather than as a therapeutic-product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wombat Capital Markets.